Granuloma formation and modulation around Schistosoma mansoni eggs that are
trapped in host tissues play a pivotal role during schistosomiasis. It has
been demonstrated that the granuloma reactions differ in patients with the
different clinical forms of the disease. The pathology during murine schis
tosomiasis has been correlated with a Th2 response while resistance to infe
ction with a Th1 type response. In humans, very little is known about the r
ole of different cytokines on the development of the disease. Here we demon
strate that IL-10 is an important cytokine regulating rite in vitro granulo
matous reactivity of PBMC from intestinal (INT) patients. This was evidence
d by rite fact that blockage of this cytokine in the in vitro granuloma ass
ay lean to a significant increase in granuloma size with cells from INT pat
ients bur not with individuals in the acute phase or with the hepatosplenic
(HS) form of schistosomiasis. These results demonstrate for the first lime
that, in context with the model, a Th2 cytokine iii human schistosomiasis
plays an important role in controlling morbidity.